ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,949Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1171

$1.3M Total Retail Price of All Prescriptions

Rank: 24 out of 1171

781 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 781 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 781 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 20,319 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 916 786 1 1
FUROSEMIDE 894 763 2 6
METOPROLOL TARTRATE 728 620 3 11
OMEPRAZOLE 703 499 4 5
HYDROCODONE-ACETAMINOPHEN 613 470 S3 5 8
LISINOPRIL 590 408 6 3
AMLODIPINE BESYLATE 586 481 7 2
LEVOTHYROXINE SODIUM 573 465 8 4
PANTOPRAZOLE SODIUM 491 411 9 29
WARFARIN SODIUM 446 402 10 12
POTASSIUM CHLORIDE 428 347 11 19
GLIMEPIRIDE 374 284 12 34
DONEPEZIL HCL 363 363 13 24
METFORMIN HCL 355 267 14 7
HYDROCHLOROTHIAZIDE 341 270 15 9
GABAPENTIN 338 253 16 16
TRAMADOL HCL 320 239 17 18
NAMENDA 299 290 18 42
FENTANYL 255 247 S2 19 89
AMOX TR-POTASSIUM CLAVULANATE 244 180 20 142
CLOPIDOGREL 241 217 21 35
METOPROLOL SUCCINATE 225 195 22 17
RANITIDINE HCL 225 187 22 38
CLONIDINE HCL 205 169 24 45
TAMSULOSIN HCL 198 185 25 28
CITALOPRAM HBR 186 165 26 22
PLAVIX 180 155 27 55
MEGESTROL ACETATE 179 159 R 28 185
ESCITALOPRAM OXALATE 177 137 29 69
KLOR-CON M10 174 142 30 125
PREDNISONE 172 148 31 39
CARVEDILOL 170 154 32 20
ACETAMINOPHEN-CODEINE 168 87 S3 33 121
LEVETIRACETAM 168 126 33 84
POLYETHYLENE GLYCOL 3350 166 139 35 72
NOVOLOG FLEXPEN 165 121 36 157
ALLOPURINOL 164 141 37 31
MIRTAZAPINE 160 153 38 50
CIPROFLOXACIN HCL 157 140 39 61
SERTRALINE HCL 154 152 40 23
LOSARTAN POTASSIUM 152 144 41 14
ATORVASTATIN CALCIUM 152 125 41 10
ATENOLOL 150 140 43 15
HYDRALAZINE HCL 146 129 44 60
IBUPROFEN 144 118 45 80
RISPERIDONE 139 117 46 77
DIOVAN 136 113 47 32
QUETIAPINE FUMARATE 134 123 48 54
PRAVASTATIN SODIUM 133 87 49 13
SULFAMETHOXAZOLE-TRIMETHOPRIM 132 110 50 109
LANTUS SOLOSTAR 131 112 51 90
LANTUS 129 96 52 46
CARBIDOPA-LEVODOPA 120 120 53 107
NEXIUM 117 99 54 25
PROMETHAZINE HCL 111 76 R 55 87
ALBUTEROL SULFATE 110 101 56 102
ZOLPIDEM TARTRATE 108 50 57 21
NYSTATIN-TRIAMCINOLONE 107 70 58 264
IPRATROPIUM-ALBUTEROL 105 100 59 130
TAMIFLU 103 98 60 276
SPIRONOLACTONE 98 95 61 53
AMLODIPINE BESYLATE-BENAZEPRIL 98 66 61 70
ENOXAPARIN SODIUM 97 87 63 227
MELOXICAM 96 81 64 56
SPIRIVA 94 72 65 57
PHENYTOIN SODIUM EXTENDED 93 27 66 137
AZITHROMYCIN 91 83 67 43
AVELOX 87 73 68 209
CEFTRIAXONE 85 81 69 232
LEVEMIR FLEXPEN 84 53 70 145
PAROXETINE HCL 83 77 71 62
CEPHALEXIN 81 74 72 104
CYCLOBENZAPRINE HCL 81 23 R 72 67
DILTIAZEM ER 80 80 74 221
FENOFIBRATE 79 38 75 81
DIGOXIN 79 79 75 68
SINGULAIR 79 51 75 78
LOVASTATIN 78 67 78 36
MECLIZINE HCL 77 71 79 115
CARAFATE 76 70 80 283
IPRATROPIUM BROMIDE 76 68 80 172
DOXAZOSIN MESYLATE 76 59 80 82
DETROL LA 76 60 80 270
HYDROXYZINE HCL 75 54 R 84 168
VANCOMYCIN HCL 75 63 84 308
LEVEMIR 74 49 86 167
THEOPHYLLINE ANHYDROUS 74 61 86 225
LAMOTRIGINE 74 61 86 216
ADVAIR DISKUS 72 51 89 51
GLIPIZIDE 71 41 90 47
METOCLOPRAMIDE HCL 71 50 90 141
BACLOFEN 71 47 90 110
KLOR-CON 10 70 52 93 126
ALENDRONATE SODIUM 69 56 94 33
CELEBREX 69 48 94 100
KLOR-CON M20 68 55 96 41
ACTOS 66 53 97 123
NIASPAN 65 48 98 136
ROPINIROLE HCL 64 63 99 119
AGGRENOX 64 58 99 148
NOVOLOG 63 62 101 94
METRONIDAZOLE 63 53 101 294
LEXAPRO 62 52 103 222
INSULIN SYRINGE 61 43 104 71
SEROQUEL 61 56 104 120
DIVALPROEX SODIUM ER 61 43 104 220
ISOSORBIDE MONONITRATE ER 60 58 107 44
OXYBUTYNIN CHLORIDE ER 59 40 108 135
NYSTATIN 59 54 108 128
ZETIA 58 37 110 63
CLONIDINE 57 41 111 229
JANUVIA 55 55 112 66
COMBIVENT 54 28 113 152
NYSTOP 52 46 114 215
PREVACID 51 49 115 317
TRIAMCINOLONE ACETONIDE 51 32 115 133
EXELON 51 51 115 164
NOVOLIN N 50 28 118 205
LACTULOSE 50 37 118 108
FLUCONAZOLE 50 40 118 195
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.